ZA200906462B - Hydrochloride salt of 5-[-3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2, 2-diphenylhexanamide - Google Patents

Hydrochloride salt of 5-[-3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2, 2-diphenylhexanamide

Info

Publication number
ZA200906462B
ZA200906462B ZA200906462A ZA200906462A ZA200906462B ZA 200906462 B ZA200906462 B ZA 200906462B ZA 200906462 A ZA200906462 A ZA 200906462A ZA 200906462 A ZA200906462 A ZA 200906462A ZA 200906462 B ZA200906462 B ZA 200906462B
Authority
ZA
South Africa
Prior art keywords
diphenylhexanamide
hydroxyphenoxy
azetidin
methyl
hydrochloride salt
Prior art date
Application number
ZA200906462A
Other languages
English (en)
Inventor
Paul Alan Glossop
Kim James
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39591485&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200906462(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of ZA200906462B publication Critical patent/ZA200906462B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200906462A 2007-03-16 2009-09-16 Hydrochloride salt of 5-[-3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2, 2-diphenylhexanamide ZA200906462B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89516307P 2007-03-16 2007-03-16

Publications (1)

Publication Number Publication Date
ZA200906462B true ZA200906462B (en) 2010-06-30

Family

ID=39591485

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200906462A ZA200906462B (en) 2007-03-16 2009-09-16 Hydrochloride salt of 5-[-3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2, 2-diphenylhexanamide

Country Status (24)

Country Link
US (1) US8263583B2 (ja)
EP (1) EP2125714B1 (ja)
JP (1) JP4277051B2 (ja)
KR (1) KR101120227B1 (ja)
CN (2) CN101641327A (ja)
AR (1) AR065714A1 (ja)
AT (1) ATE512132T1 (ja)
AU (1) AU2008247095B2 (ja)
BR (1) BRPI0808413A2 (ja)
CA (1) CA2678683C (ja)
CY (1) CY1111701T1 (ja)
DK (1) DK2125714T3 (ja)
ES (1) ES2364727T3 (ja)
HK (1) HK1189591A1 (ja)
IL (1) IL200403A (ja)
MX (1) MX2009009952A (ja)
NZ (1) NZ579056A (ja)
PL (1) PL2125714T3 (ja)
PT (1) PT2125714E (ja)
RU (1) RU2422439C2 (ja)
SI (1) SI2125714T1 (ja)
TW (1) TWI348907B (ja)
WO (1) WO2008135819A1 (ja)
ZA (1) ZA200906462B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012005859A (es) 2009-11-23 2012-12-17 Palatin Technologies Inc Peptidos lineales especificos del receptor de melanocortina-1.
EA021897B1 (ru) 2009-11-23 2015-09-30 Палатин Текнолоджиз, Инк. Циклические пептиды, специфичные к рецептору меланокортина-1
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP3596046A1 (en) 2017-03-15 2020-01-22 Mylan Laboratories Ltd. Novel polymorphs of (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide hydrochloride
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071144A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION
US20220380307A1 (en) * 2019-06-25 2022-12-01 Mylan Laboratories Limited Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
AU2021296221A1 (en) * 2020-06-26 2023-02-02 Mylan Pharma Uk Limited Formulations including 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide
CN113577059B (zh) * 2021-08-02 2022-05-20 山东大学齐鲁医院(青岛) 一种用于小儿哮喘的活性药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948964B1 (en) 1996-12-02 2003-04-02 Kyorin Pharmaceutical Co., Ltd. Novel n-substituted pyrrolidine derivatives and process for preparing the same
JPH11100366A (ja) * 1997-09-29 1999-04-13 Kyorin Pharmaceut Co Ltd 新規ｎ−置換環状アミン誘導体及びその製造法
NZ566023A (en) * 2005-09-21 2010-02-26 Pfizer Ltd Carboxamide derivatives as muscarinic receptor antagonists
EP2066626B1 (en) * 2006-09-22 2010-03-17 Pfizer Limited Azetidine derivatives as muscarinic receptor antagonists

Also Published As

Publication number Publication date
ES2364727T3 (es) 2011-09-13
SI2125714T1 (sl) 2011-10-28
US8263583B2 (en) 2012-09-11
PT2125714E (pt) 2011-07-14
EP2125714B1 (en) 2011-06-08
TWI348907B (en) 2011-09-21
KR20090110944A (ko) 2009-10-23
WO2008135819A1 (en) 2008-11-13
AU2008247095B2 (en) 2012-12-13
CA2678683C (en) 2012-05-15
CN103351367B (zh) 2015-06-10
RU2422439C2 (ru) 2011-06-27
NZ579056A (en) 2011-07-29
CA2678683A1 (en) 2008-11-13
RU2009134512A (ru) 2011-03-20
CY1111701T1 (el) 2015-10-07
CN101641327A (zh) 2010-02-03
TW200904408A (en) 2009-02-01
JP2009001543A (ja) 2009-01-08
AR065714A1 (es) 2009-06-24
US20100113409A1 (en) 2010-05-06
MX2009009952A (es) 2009-10-08
IL200403A0 (en) 2010-04-29
ATE512132T1 (de) 2011-06-15
IL200403A (en) 2014-08-31
DK2125714T3 (da) 2011-07-25
KR101120227B1 (ko) 2012-03-20
BRPI0808413A2 (pt) 2014-07-15
HK1189591A1 (en) 2014-06-13
JP4277051B2 (ja) 2009-06-10
WO2008135819A8 (en) 2009-08-27
EP2125714A1 (en) 2009-12-02
CN103351367A (zh) 2013-10-16
AU2008247095A1 (en) 2008-11-13
PL2125714T3 (pl) 2011-10-31

Similar Documents

Publication Publication Date Title
HUS000509I2 (hu) Abemaciklib vagy egy gyógyászatilag elfogadható sója
ZA200906462B (en) Hydrochloride salt of 5-[-3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2, 2-diphenylhexanamide
TWI371277B (en) Salt form
IL200122A0 (en) Diaminopyrimidines as fungicides
IL205071A0 (en) Azolecarboxamide compound or salt thereof
PL2136629T3 (pl) Fenoksyfenyloamidyny jako fungicydy
LT3090730T (lt) Tabletės, kurių sudėtyje yra eltrombopago olamino
EP2305641A4 (en) SULPHONAMIDE COMPOUND OR SALT THEREOF
PL1981866T3 (pl) N-Cyklopropylo-N-benzyloamidy jako środki grzybobójcze
EP2141990A4 (en) ACTIVE COMPOUNDS ON 11BETA-HSD1
GB0704906D0 (en) Fungicides
GB0717258D0 (en) Novel fungicides
ZA201001229B (en) Novel fungicides
EP2166859A4 (en) QUINAZOLINE SALT COMPOUNDS
GB0717256D0 (en) Novel fungicides
IL201625A0 (en) Arylamide pyrimidone compounds
IL212403A0 (en) Carbamate compound or salt thereof
HU0600293D0 (en) New rosuvastatine salt
GB0702382D0 (en) New salt
GB0701574D0 (en) Wave-dissipating block
IL214110A0 (en) 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
GB0703998D0 (en) Novel salt
GB0800840D0 (en) Novel salt
GB0806341D0 (en) Reduced sodium salt